Article
Generation of two iPSC lines each carrying a stop codon mutation, c.366T > A (p.Y122X) and c.1657C > T (p.R553X), in the CFTR gene from the parental line PCIi033-A using CRISPR/Cas9.
Stem cell research - 1 Aug 2026
Simonneau Benjamin, Mienanzambi Stecy, Baghdoyan Sandrine, Cailleret Michel, Simon Stéphanie, Ruckebusch Odile, Vrablikova Barbora, Giraud-Triboult Karine, Kassar Lina El, Fanen Pascale, Duriez Bénédicte
Abstract excerpt
Cystic fibrosis is a recessive genetic disease due to mutations in the CFTR gene. Approximately 80% of patients carry the CFTR-F508del mutation and may benefit from the triple therapy Kaftrio®. However, patients with other rare mutations that prevent the production of the CFTR protein, such as nonsense mutations, have no available treatments. With CRISPR/Cas tools, we generate two iPSC lines bearing stop-codon...
Topics
Join the communities discussing this publication.
